As daylight fades across India — from dense urban apartments to rural homes — a daily ritual plays out: plug in the liquid vaporiser, light the coil, apply the lotion. Mosquito repellent products are not discretionary purchases in most of India; they are household necessities driven by genuine health risk. India recorded 2.89 lakh dengue cases in 2023 (NVBDCP) and 1.69 lakh malaria cases — and these are only the reported numbers.
India's mosquito repellent market has evolved significantly. A decade ago, it was dominated by a few synthetic chemical coils and mats. Today, it includes liquid vaporisers, aerosols, electronic ultrasonic devices, patch-based repellents, herbal and Ayurvedic formulations, and specialised products for children. Each sub-category is an entry point with different capital requirements, regulatory pathways, and target consumers.
|
2.89 lakh confirmed dengue cases in India in 2023 (NVBDCP) — with actual incidence estimated at 10–15x reported figures. Combined with 1.69 lakh malaria cases, India's mosquito repellent market has a disease-driven demand floor that is structurally inelastic to economic cycles.
|
|
India Mosquito Repellent Market Size (FY2024)
|
₹6,500 crore (approx.) — FICCI industry estimate
|
|
Market CAGR (2024–2030)
|
9–11% (FICCI estimate; herbal segment growing faster at 15–18%)
|
|
Minimum Entry Investment (MSME)
|
₹20 lakh (coil unit) to ₹1.5 crore (liquid vaporiser and herbal range)
|
|
Key Manufacturing States
|
Gujarat, Maharashtra, Uttar Pradesh, Andhra Pradesh, Karnataka, West Bengal
|
|
Primary Regulatory Requirement
|
Registration under Insecticides Act, 1968 via CIBRC
|
|
India Dengue Cases (2023)
|
2.89 lakh confirmed — NVBDCP
|
Why Mosquito Repellent Manufacturing Is One of India's Most Recession-Proof Business Opportunities
Demand for mosquito repellent products is non-cyclical. Mosquitoes do not observe economic downturns, and consumer spending on repellents holds even when other FMCG categories contract. This defensive demand characteristic makes the sector one of the most resilient manufacturing categories available to an MSME investor — validated by consistent category growth even during COVID-19 lockdowns.
The herbal repellent opportunity is the most compelling growth story within this sector. Consumers are increasingly concerned about the health effects of synthetic pyrethroids — the active ingredients in most conventional coils and vaporisers. This concern is driving rapid growth in neem oil, citronella, eucalyptus, and Ayurvedic formulation-based repellents. The Ministry of Ayush has established a dedicated licensing pathway for herbal insect repellents.
Climate change is extending the mosquito season in many Indian states. Higher temperatures and irregular rainfall mean that breeding seasons that previously lasted 5–6 months in northern India now last 8–9 months. This secular trend is expanding the demand calendar for repellent manufacturers — good news for production planning and capital utilisation.
|
USD 85 million in insecticide and mosquito repellent exports from India in FY2023–24 (CHEMEXCIL), growing at 8–10% annually. Africa and Southeast Asia are primary export markets — where Indian mosquito coils are preferred for their cost-competitiveness and year-round disease burden.
|
India's Mosquito Repellent Market: Demand Data and Segment Breakdown
India's mosquito repellent industry is segmented by product type and formulation. By product, coils are the dominant volume category (primarily rural and semi-urban); liquid vaporisers are the highest-growth urban product; mats are intermediate; aerosol sprays serve premium and travel segments; herbal formulations are the fastest-growing emerging category.
Year-Wise India Mosquito Repellent Market Data
|
Year
|
Market Size (₹ Crore)
|
Herbal Segment (₹ Crore est.)
|
Key Trend
|
|
FY2019–20
|
4,200
|
280
|
Synthetic coil and mat dominant; liquid vaporiser gaining
|
|
FY2020–21
|
4,600
|
380
|
COVID heightens disease anxiety; repellent demand spikes
|
|
FY2021–22
|
5,100
|
490
|
Herbal interest grows; Ministry of Ayush norms strengthened
|
|
FY2022–23
|
5,700
|
650
|
Electronic repellents and patch products emerge in urban markets
|
|
FY2023–24
|
6,500
|
870
|
Dengue 2.89L cases drives peak demand; CHEMEXCIL exports USD 85Mn
|
|
FY2026–27 (est.)
|
8,700
|
1,400
|
Assumed CAGR 10%; herbal at 15% CAGR; vaporiser urban penetration peaks
|
|
FY2029–30 (est.)
|
11,600
|
2,200
|
Assumed CAGR 10%; climate-extended seasons boost rural demand
|
|
FY2034–35 (est.)
|
18,000
|
4,000
|
Assumed CAGR 9%; herbal/Ayush regulatory streamlining drives share gain
|
Note: FY2026–27 onward are industry estimates based on an assumed CAGR of 9–10% for overall market and 14–15% for herbal segment. Not certified government figures.
Government Data That Every Mosquito Repellent Entrepreneur Needs to Know
NVBDCP disease burden data is the most important government data source for this sector — it confirms both the disease burden that drives consumer demand and the government's public health spending on vector control, which complements rather than replaces private household spending on repellents.
CIBRC data shows approximately 8,000+ registered insecticide formulations in India, confirming a large and active manufacturing ecosystem where new entrants can innovate on formulation, format, and delivery mechanism while building on established active ingredient registrations. The Ministry of Ayush has established specific guidelines for herbal and Ayurvedic insect repellent registration — separate from CIBRC, which covers chemical insecticides.
Government & Department Statistics: Mosquito Repellent Sector
|
Parameter
|
Figure
|
Source & Year
|
|
Dengue Cases (India)
|
2,89,000 confirmed
|
NVBDCP, 2023
|
|
Malaria Cases (India)
|
1,69,000 confirmed
|
NVBDCP, 2023
|
|
Insecticide Export Value
|
USD 85 million
|
CHEMEXCIL, FY2023–24
|
|
Registered Insecticide Formulations (CIBRC)
|
8,000+
|
CIBRC, 2024
|
|
Insecticides Act 1968
|
Governing Framework
|
Ministry of Agriculture & Farmers Welfare
|
|
BIS IS:12479 (Mosquito Coil) — Mandatory
|
Yes
|
BIS, 2024
|
|
Ministry of Ayush Herbal Repellent Guideline
|
Active
|
Ministry of Ayush, 2022
|
|
States with Highest Dengue Burden
|
Kerala, Maharashtra, Karnataka, UP, Delhi
|
NVBDCP, 2023
|
Government Schemes and Financial Support for Mosquito Repellent Manufacturers
MSME Udyam registration unlocks CGTMSE collateral-free loans up to ₹5 crore, priority sector lending, and the CLCSS subsidy — 15% upfront on technology investment loans up to ₹1 crore. For a liquid vaporiser filling line or herbal formulation facility, CLCSS can materially reduce effective equipment cost.
Startup India (DPIIT) is particularly relevant for entrepreneurs developing innovative repellent formats — patch-based repellents, ultrasonic electronic devices, herbal spatial diffusers. For herbal repellent manufacturers, the Ministry of Ayush's cluster development programme and National AYUSH Mission fund provide support for Ayurvedic manufacturing units, including herbal extraction infrastructure and GMP compliance upgrades.
|
Practitioners' Insight: CIBRC registration is non-negotiable — but it doesn't need to be a barrier. If you plan to manufacture a formulation using an already-registered active ingredient (e.g. allethrin for coils, prallethrin for vaporisers), you can apply for registration based on the existing data rather than conducting fresh toxicology studies. This significantly reduces both time and cost. Many first-time manufacturers lose months by not understanding this 'me-too' registration pathway. Engage a CIBRC-registered regulatory consultant before submitting any application.
|
Export Markets and Import Substitution for Indian Repellent Manufacturers
Indian mosquito repellents — primarily coils and mats — are exported to sub-Saharan Africa, Southeast Asia, Bangladesh, Sri Lanka, and the Middle East. These markets share India's tropical disease burden but have smaller domestic manufacturing capacities.
The herbal repellent export opportunity is globally significant. Consumer markets in Europe, North America, and Australia are actively seeking natural alternatives to DEET-based repellents. Indian herbal formulations — neem, citronella, eucalyptus, Ayurvedic blends — are well-positioned for these markets if they can demonstrate clinical efficacy and obtain country-specific certification (EU Biocidal Products Regulation, EPA registration for USA).
Major Indian Companies in Mosquito Repellent Manufacturing
|
Company / Brand
|
Product Range
|
Note
|
|
Godrej Consumer Products (Good Knight)
|
Vaporisers, Coils, Mats, Aerosols
|
India's #1 repellent brand by market share; pioneers liquid vaporiser category
|
|
Reckitt Benckiser India (Mortein)
|
Coils, Vaporisers, Aerosols
|
UK-origin brand dominant in South and East India; aerosol category leader
|
|
SC Johnson (All Out)
|
Vaporisers, Mats, Coils
|
US-origin brand; inventor of All Out electric mat; strong Tier-2/3 penetration
|
|
Dabur India (Odomos)
|
Herbal Cream, Lotion, Patch
|
Pioneer of consumer herbal repellent in India; AYUSH-compliant natural formulations
|
|
Hindustan Unilever (Lifebuoy Mosquito)
|
Patches, Sprays
|
Entry into repellent category with DEET-free, natural-positioning products
|
|
Herbal Strategi
|
Herbal Repellents (DEET-free)
|
Bengaluru-based MSME startup; certified natural repellents for premium and export markets
|
|
Saathi Kendra / Surya Agrokem
|
Coils, Mats (B2B)
|
MSME-scale coil and mat manufacturers supplying private labels and rural cooperative brands
|
|
Kama Ayurveda / Forest Essentials
|
Herbal Formulations
|
Premium Ayurvedic personal care companies with herbal repellent adjacent products
|
The Growth Horizon: India's Mosquito Repellent Market Through 2035
At an assumed CAGR of 9%, India's mosquito repellent market is projected to reach approximately ₹18,000 crore by FY2035. The herbal and natural segment, growing at 14–15% CAGR, will account for 20–25% of total market value by 2035 versus approximately 13% today.
Electronic repellents — ultrasonic devices, smart vaporisers with timer and dosage control — represent a premium segment that will scale with rising urban middle-class incomes. An MSME that develops or assembles a smart mosquito repellent device targeting a consumer willing to pay a 5–10x premium over a commodity coil enters the highest-margin segment in this category.
Practitioner Q&A: Starting a Mosquito Repellent Manufacturing Business in India
Q: What is the primary regulatory requirement for mosquito repellent manufacturing in India?
A: All insecticide-based mosquito repellents — coils, mats, liquid vaporisers, aerosols — require registration under the Insecticides Act, 1968, administered by CIBRC. For herbal repellents with no synthetic insecticide active ingredients, registration under the Ministry of Ayush (Ayurvedic Manufacturing Licence) is an alternative pathway. Always confirm which regulatory pathway applies to your specific formulation before starting.
Q: What is the BIS standard for mosquito coils and is it mandatory?
A: BIS IS:12479 covers mosquito coils — it specifies composition, burning characteristics, active ingredient concentration, and labelling requirements. Compliance is mandatory under the Quality Control Order for mosquito coils. Manufacturers must apply for BIS product certification through the BIS online portal. The process includes factory inspection, product testing at a NABL-accredited laboratory, and ongoing annual surveillance.
Q: How does the CIBRC 'me-too' registration pathway work?
A: For a new product using an already-registered active ingredient (allethrin, prallethrin, transfluthrin, deltamethrin), the applicant can rely on existing toxicology data for that active ingredient — submitting only formulation-specific data rather than conducting new animal toxicology studies. This reduces cost from ₹20–30 lakh for full studies to ₹2–5 lakh and cuts timeline from 24+ months to 6–12 months.
Q: What is the minimum investment to start a mosquito coil manufacturing unit?
A: A small-scale mosquito coil manufacturing unit can be set up for ₹20–40 lakh, covering coil mixing and moulding equipment, drying facility, packaging line, raw material inventory, and initial working capital. Factory space of 2,000–3,000 sq ft is adequate for 100–200 kg/day production. CIBRC registration, BIS certification, SPCB consent, and factory licence are all required before formal commercial production.
Q: Which states are best for setting up a mosquito repellent manufacturing unit?
A: Gujarat and Maharashtra are preferred for chemical-based repellent manufacturing due to chemical raw material supply chains and logistics infrastructure. Uttar Pradesh is preferred for coil manufacturing due to low-cost labour and proximity to North Indian markets. Karnataka and Andhra Pradesh offer advantages for herbal repellent manufacturers due to access to neem, citronella, and eucalyptus essential oils.
Q: How do I access CHEMEXCIL support as a new repellent exporter?
A: Apply for CHEMEXCIL membership (annual fee based on export turnover tier). As a member, you receive market development assistance — partial reimbursement of international trade fair participation, access to verified importer databases in Africa, Southeast Asia, and the Middle East, and guidance on country-specific registration requirements.
Q: What is the profitability of mosquito coil vs liquid vaporiser manufacturing?
A: Mosquito coils have lower gross margins (20–30%) but higher volumes. Liquid vaporiser refills have higher gross margins (35–50%) and create recurring revenue through the device-and-consumable model — once your device is adopted, the household buys your refills repeatedly. The herbal segment commands the highest gross margins (45–60%) and the lowest price elasticity among repellent-conscious consumers.
Q: Can an MSME manufacture private-label mosquito repellents for large brands?
A: Yes — and this is a common and financially sound model for MSME entry. Large brands like Good Knight and Mortein outsource significant manufacturing volumes to licensed contract manufacturers. To be considered, you need CIBRC registration for the relevant formulations, BIS certification, SPCB consent, factory licence, and demonstrated quality control capability.
Q: What herbal ingredients are most effective in mosquito repellents and legally permitted?
A: The most widely used herbal active ingredients in India are citronella oil, neem oil, eucalyptus oil (OLE), and pyrethrum (natural pyrethrin). All are permitted under Ministry of Ayush guidelines for herbal repellent formulations. Formulations must demonstrate efficacy through standard testing at a NABL-accredited laboratory. Ministry of Ayush GMP standards apply to the manufacturing facility for Ayush-licensed products.
Q: How do I build distribution for a new mosquito repellent brand in rural markets?
A: Rural distribution works through a three-tier system: stockist (state or district level) → wholesale distributor → retail (kirana stores, pharmacies, agri shops). For a new brand, the most effective entry strategy is regional — saturate 2–3 districts before expanding state-wide. Offering attractive schemes to stockists in the first season is standard practice. Rural brand-building happens through below-the-line marketing: wall paintings, local cable TV, mobile van demonstrations.
The Bottom Line
India's mosquito repellent market is one of the most defensively resilient manufacturing opportunities available to an MSME entrepreneur. Disease-driven demand creates a structural floor; rising incomes and urban premiumisation create growth in higher-margin segments; and climate change is extending the demand season.
Government support is real: CGTMSE collateral-free loans, CLCSS equipment subsidies, DPIIT Startup India recognition for innovative formats, Ministry of Ayush support for herbal manufacturers, and CHEMEXCIL export promotion. The regulatory pathway — CIBRC registration for synthetic formulations, Ayush licence for herbal — is navigable with professional support within 6–12 months.
The most important first step: choose your formulation category and regulatory pathway. Engage a CIBRC-registered consultant, register under Udyam, secure SPCB consent, and begin BIS certification alongside production planning. Starting a mosquito repellent manufacturing business in India today puts you in a sector where demand is guaranteed by disease ecology and growth is driven by premium product innovation.
References
1. NVBDCP — Dengue and malaria case data 2023 (dengue: 2.89 lakh; malaria: 1.69 lakh)
2. CHEMEXCIL — Insecticide and repellent export data FY2023–24 (USD 85 million)
3. CIBRC — Registered formulation database; Insecticides Act 1968 regulatory framework
4. BIS — IS:12479 mosquito coil standard; mandatory certification requirements
5. Ministry of Ayush — Herbal and Ayurvedic insect repellent manufacturing licence guidelines (2022)
6. FICCI — Consumer Healthcare and FMCG Industry Report: India mosquito repellent market size and CAGR estimates
